
Steven Jungerwirth
R&D executive with global experience across a range of therapeutic areas (prescription and non-prescription) and disciplines. Passionate... | Glencoe, Illinois, United States
*50 free lookup(s) per month.
No credit card required.
Steven Jungerwirth’s Emails st****@ab****.com
Steven Jungerwirth’s Phone Numbers No phone number available.
Social Media
Steven Jungerwirth’s Location Glencoe, Illinois, United States
Steven Jungerwirth’s Expertise R&D executive with global experience across a range of therapeutic areas (prescription and non-prescription) and disciplines. Passionate leader with a consistent record of building big brands and strengthening organizational capability. Led the development and lifecycle management of numerous successful products, including three blockbusters (Cipro, Actonel and Humira). Designed/executed the ABT-494 Rheumatoid Arthritis Phase 2 program, with rapid transition to Phase 3. Expertise integrating drug development data across scientific disciplines to make the best decisions. Deep understanding of drug safety; including clinical study, epidemiology, post-marketing safety surveillance and regulatory reporting requirements. Expertise working in alliances with large and small partners. Sought out by top management to lead the biggest projects and the most challenging situations. Specialties: Clinical Development Regulatory Affairs Pharmacovigilance and Risk Management Product Lifecycle Management Medical Affairs & Commercial Support Organization Design/Effectiveness/Teambuilding Across Cultures
Steven Jungerwirth’s Current Industry Retired
Steven
Jungerwirth’s Prior Industry
Bayer Pharmaceuticals
|
Yale University School Of Medicine
|
Procter And Gamble Pharmaceuticals
|
Procter And Gamble
|
Abbvie Pharmaceuticals
|
Retired
Not the Steven Jungerwirth you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Retired
Enjoying life, traveling and taking pictures
Fri May 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Abbvie Pharmaceuticals
Project Director, Humira/Immunology Pharmaceutical Development
Mon Jul 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Apr 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Abbvie Pharmaceuticals
Group Head, Clinical Safety Evaluation, Global Pharmacovigilance
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jul 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Procter And Gamble
Director Product Safety and Regulatory Affairs
Thu Oct 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Procter And Gamble Pharmaceuticals
Director, Clinical Development, Regulatory Affairs and Safety
Sat Aug 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Oct 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Yale University School Of Medicine
Clinical Instructor, Infectious Diseases
Mon Jan 01 1990 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jan 01 1995 00:00:00 GMT+0000 (Coordinated Universal Time)
Bayer Pharmaceuticals
Vice President, Anti-Infective and Biologics
Sun Jan 01 1989 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)